Cargando…

Multidimensional Impact of Mediterranean Diet on IBD Patients

BACKGROUND & AIMS: Malnutrition with the accumulation of fat tissue and nonalcoholic fatty liver disease (NAFLD) are conditions associated with inflammatory bowel disease (IBD). Visceral fat and NAFLD-related liver dysfunction can both worsen intestinal inflammation. Because the Mediterranean di...

Descripción completa

Detalles Bibliográficos
Autores principales: Chicco, Fabio, Magrì, Salvatore, Cingolani, Arianna, Paduano, Danilo, Pesenti, Mario, Zara, Federica, Tumbarello, Francesca, Urru, Emanuela, Melis, Alessandro, Casula, Laura, Fantini, Massimo Claudio, Usai, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737160/
https://www.ncbi.nlm.nih.gov/pubmed/32440680
http://dx.doi.org/10.1093/ibd/izaa097
_version_ 1783622896079339520
author Chicco, Fabio
Magrì, Salvatore
Cingolani, Arianna
Paduano, Danilo
Pesenti, Mario
Zara, Federica
Tumbarello, Francesca
Urru, Emanuela
Melis, Alessandro
Casula, Laura
Fantini, Massimo Claudio
Usai, Paolo
author_facet Chicco, Fabio
Magrì, Salvatore
Cingolani, Arianna
Paduano, Danilo
Pesenti, Mario
Zara, Federica
Tumbarello, Francesca
Urru, Emanuela
Melis, Alessandro
Casula, Laura
Fantini, Massimo Claudio
Usai, Paolo
author_sort Chicco, Fabio
collection PubMed
description BACKGROUND & AIMS: Malnutrition with the accumulation of fat tissue and nonalcoholic fatty liver disease (NAFLD) are conditions associated with inflammatory bowel disease (IBD). Visceral fat and NAFLD-related liver dysfunction can both worsen intestinal inflammation. Because the Mediterranean diet (Md) has been shown to ameliorate both obesity and NAFLD, the aim of this study was to analyze the impact of Md on the nutritional state, liver steatosis, clinical disease activity, and quality of life (QoL) in IBD patients. METHODS: Patients with IBD, both Crohn’s disease (CD) and ulcerative colitis (UC), followed Md for 6 months. Their body mass index (BMI), body tissue composition, liver steatosis and function, serum lipid profile, clinical disease activity, and inflammatory biomarkers (C-reactive protein and fecal calprotectin) were collected at baseline (T0) and compared with those obtained after 6 months (T180) to evaluate the impact of Md. RESULTS: One hundred forty-two IBD patients, 84 UC and 58 CD, followed Md for 6 months. At T180, diet-adherent CD and UC improved BMI (UC −0.42, P = 0.002; CD −0.48, P = 0.032) and waist circumference (UC −1.25 cm, P = 0.037; CD −1.37 cm, P = 0.041). Additionally, the number of patients affected by liver steatosis of any grade was significantly reduced in both groups (UC T0 31 of 84 [36.9%] vs T180 18 of 84 [21.4%], P = 0.0016; CD T0 27 of 58 [46.6%] vs T180 18 of 58 [31.0%], P < 0.001) after dietary intervention. Finally, after 6 months of the diet, fewer UC and CD patients with stable therapy had active disease (UC T0 14 of 59 [23.7%] vs T180 4 of 59 [6.8%], P = 0.004; CD T0 9 of 51 [17.6%] vs T180 2 of 51 [3.0%], P = 0.011) and elevated inflammatory biomarkers. Mediterranean diet improved QoL in both UC and CD, but neither serum lipid profile nor liver function were modified by the diet. CONCLUSIONS: A significant reduction of malnutrition-related parameters and liver steatosis was observed in both CD and UC patients after short-term dietary intervention based on the adoption of Md, and this was associated with a spontaneous improvement of disease activity and inflammatory markers.
format Online
Article
Text
id pubmed-7737160
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77371602020-12-17 Multidimensional Impact of Mediterranean Diet on IBD Patients Chicco, Fabio Magrì, Salvatore Cingolani, Arianna Paduano, Danilo Pesenti, Mario Zara, Federica Tumbarello, Francesca Urru, Emanuela Melis, Alessandro Casula, Laura Fantini, Massimo Claudio Usai, Paolo Inflamm Bowel Dis Leading Off BACKGROUND & AIMS: Malnutrition with the accumulation of fat tissue and nonalcoholic fatty liver disease (NAFLD) are conditions associated with inflammatory bowel disease (IBD). Visceral fat and NAFLD-related liver dysfunction can both worsen intestinal inflammation. Because the Mediterranean diet (Md) has been shown to ameliorate both obesity and NAFLD, the aim of this study was to analyze the impact of Md on the nutritional state, liver steatosis, clinical disease activity, and quality of life (QoL) in IBD patients. METHODS: Patients with IBD, both Crohn’s disease (CD) and ulcerative colitis (UC), followed Md for 6 months. Their body mass index (BMI), body tissue composition, liver steatosis and function, serum lipid profile, clinical disease activity, and inflammatory biomarkers (C-reactive protein and fecal calprotectin) were collected at baseline (T0) and compared with those obtained after 6 months (T180) to evaluate the impact of Md. RESULTS: One hundred forty-two IBD patients, 84 UC and 58 CD, followed Md for 6 months. At T180, diet-adherent CD and UC improved BMI (UC −0.42, P = 0.002; CD −0.48, P = 0.032) and waist circumference (UC −1.25 cm, P = 0.037; CD −1.37 cm, P = 0.041). Additionally, the number of patients affected by liver steatosis of any grade was significantly reduced in both groups (UC T0 31 of 84 [36.9%] vs T180 18 of 84 [21.4%], P = 0.0016; CD T0 27 of 58 [46.6%] vs T180 18 of 58 [31.0%], P < 0.001) after dietary intervention. Finally, after 6 months of the diet, fewer UC and CD patients with stable therapy had active disease (UC T0 14 of 59 [23.7%] vs T180 4 of 59 [6.8%], P = 0.004; CD T0 9 of 51 [17.6%] vs T180 2 of 51 [3.0%], P = 0.011) and elevated inflammatory biomarkers. Mediterranean diet improved QoL in both UC and CD, but neither serum lipid profile nor liver function were modified by the diet. CONCLUSIONS: A significant reduction of malnutrition-related parameters and liver steatosis was observed in both CD and UC patients after short-term dietary intervention based on the adoption of Md, and this was associated with a spontaneous improvement of disease activity and inflammatory markers. Oxford University Press 2020-05-22 /pmc/articles/PMC7737160/ /pubmed/32440680 http://dx.doi.org/10.1093/ibd/izaa097 Text en © 2020 Crohn’s & Colitis Foundation. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Leading Off
Chicco, Fabio
Magrì, Salvatore
Cingolani, Arianna
Paduano, Danilo
Pesenti, Mario
Zara, Federica
Tumbarello, Francesca
Urru, Emanuela
Melis, Alessandro
Casula, Laura
Fantini, Massimo Claudio
Usai, Paolo
Multidimensional Impact of Mediterranean Diet on IBD Patients
title Multidimensional Impact of Mediterranean Diet on IBD Patients
title_full Multidimensional Impact of Mediterranean Diet on IBD Patients
title_fullStr Multidimensional Impact of Mediterranean Diet on IBD Patients
title_full_unstemmed Multidimensional Impact of Mediterranean Diet on IBD Patients
title_short Multidimensional Impact of Mediterranean Diet on IBD Patients
title_sort multidimensional impact of mediterranean diet on ibd patients
topic Leading Off
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737160/
https://www.ncbi.nlm.nih.gov/pubmed/32440680
http://dx.doi.org/10.1093/ibd/izaa097
work_keys_str_mv AT chiccofabio multidimensionalimpactofmediterraneandietonibdpatients
AT magrisalvatore multidimensionalimpactofmediterraneandietonibdpatients
AT cingolaniarianna multidimensionalimpactofmediterraneandietonibdpatients
AT paduanodanilo multidimensionalimpactofmediterraneandietonibdpatients
AT pesentimario multidimensionalimpactofmediterraneandietonibdpatients
AT zarafederica multidimensionalimpactofmediterraneandietonibdpatients
AT tumbarellofrancesca multidimensionalimpactofmediterraneandietonibdpatients
AT urruemanuela multidimensionalimpactofmediterraneandietonibdpatients
AT melisalessandro multidimensionalimpactofmediterraneandietonibdpatients
AT casulalaura multidimensionalimpactofmediterraneandietonibdpatients
AT fantinimassimoclaudio multidimensionalimpactofmediterraneandietonibdpatients
AT usaipaolo multidimensionalimpactofmediterraneandietonibdpatients